Next Century Growth Investors’s Collegium Pharmaceutical COLL Stock Holding History

Next Century Growth Investors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-122,857	Closed	-$2.93M	–	139
2018 Q2	$2.93M	Sell	122,857 -37,186	-23%	-$914K	0.37%	85
2018 Q1	$4.09M	Buy	160,043 +15,071	+10%	+$359K	0.55%	61
2017 Q4	$2.68M	Buy	+144,972	New	+$2.08M	0.33%	85

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Next Century Growth Investors's COLL Position: Q3 2018 in Review

Next Century Growth Investors sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 122,857 shares — an estimated $2.93M sold.

Next Century Growth Investors first reported a position in COLL in Q4 2017 and held it in 3 quarters. The position peaked at $4.09M in Q1 2018. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

Next Century Growth Investors reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Next Century Growth Investors sold 122,857 Collegium Pharmaceutical shares in Q3 2018, an estimated $2.93M.
Next Century Growth Investors first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 3 quarters.
Next Century Growth Investors's Collegium Pharmaceutical position peaked at $4.09M in Q1 2018.
124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on Next Century Growth Investors's 13F filing for Q3 2018, filed 14 Nov 2018.